Empowering cancer care in Africa

Do all hormone sensitive prostate cancers need triplet therapy?

Molecular assay may help identify NSCLC patients who could benefit from adjuvant chemotherapy

Insights into germline genetic screening of breast cancer patients

IDH2 mutation associated with favourable outcome in older adults with newly diagnosed ALL treated with lower-intensity therapy

Demographics, characteristics, survival and outcomes in older, untreated, AML with NPM1 mutations or KMT2A rearrangements

Bladder cancer updates from the second half of 2024

Multiple Myeloma: evolving paradigm - Panel Discussion

Head & Neck - BMC Data

Choosing the right patients for transplant

CAR-T - Choosing Wisely

Choosing Wisely for young women with breast cancer: BMC data